You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 84 No. 3, September 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (489)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Systemic Scleroderma

A Clinical Study of 727 Cases

DENNY L. TUFFANELLI, M.D.; R. K. WINKELMANN, M.D.

Arch Dermatol. 1961;84(3):359-371.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Scleroderma was described centuries ago, and yet today the physician has little to offer other than the diagnosis. The etiology remains obscure; the course is unpredictable, and therapy is of little benefit. The term "scleroderma" is limited, for literally it means merely "hard skin." Under this label are included disease processes varying from the sclerosis of a bit of skin to overwhelming systemic reactions terminating in rapid death. While innumerable case reports and reviews of scleroderma have appeared in the literature, we believed that a longterm clinical study, unique in the extremely large number of patients observed, would add to our knowledge of a poorly understood entity.

Classification

The classification of scleroderma used in the Section of Dermatology at the Mayo Clinic is as follows:

  1. Localized
    1. Morphea
    2. Generalized morphea
    3. Linear scleroderma
      1. En coup de sabre
      2. Hemiatrophy


  2. Systemic
    1. Acrosclerosis
    2. Diffuse scleroderma

In this paper we will be concerned only with the . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN.

Fellow in Dermatology, Mayo Foundation (Dr. Tuffanelli); Section of Dermatology, Mayo Clinic and Mayo Foundation (Dr. Winkelmann).


Footnotes

Submitted for publication June 14, 1961.

Abridgment of thesis submitted by Dr. Tuffanelli to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements for the degree of Master of Science in Dermatology.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.